NCT06809829 Evaluation of Doxycycline Nanoparticle With Gelatin Sponge on Immediate Implant in Esthetic Region
| NCT ID | NCT06809829 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kafrelsheikh University |
| Condition | Immediate Implant Placement |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2025-02 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16 participants in total. It began in 2025-02 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to Evaluate the effect of Doxycycline nanoparticles along with gelatin sponge in immediate implant cases in esthetic zone. The main question it aims to answer is: Does the application of doxycycline nanoparticles with gelatin sponge improve the clinical and radiographic outcomes of immediate implant cases in esthetic zone? Researchers will compare eight patients undergoing immediate implant placement with the buccal gap filled with doxycycline loaded gelatin nanoparticles along with gelatin sponge (group A) with eight patients undergoing immediate implant placement with the buccal gap filled with doxycycline along with gelatin sponge (group B). to see if the doxycycline loaded nanoparticles will improve the clinical and radiographic outcomes of the immediate implant . Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].
Eligibility Criteria
Inclusion Criteria: * The presence of non-restorable single-rooted maxillary centrals, canines or premolars. * Sufficient bone volume. * Good oral hygiene. * The remaining space between the socket and the fixture equals or more than 2mm at the coronal third of the socket. * Sufficient bone width (≥ 1 mm) in the buccal plate of the remaining bone to place an implant confirmed by cone beam computer tomography (CBCT). Exclusion Criteria: * Insufficient bone volume. * Active infection. * Patients on chemotherapy or radiotherapy. * Patients who have systemic disorders {uncontrolled diabetes mellitus, autoimmune disease, …etc}, * Pregnant patients, * Patients with bone diseases * Presence of periapical pathology affecting the neighbouring teeth. * Smokers.
Frequently Asked Questions
Who can join the NCT06809829 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Immediate Implant Placement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06809829 currently recruiting?
Yes, NCT06809829 is actively recruiting participants. Visit ClinicalTrials.gov or contact Kafrelsheikh University to inquire about joining.
Where is the NCT06809829 trial being conducted?
This trial is being conducted at Kafrelsheikh, Egypt.
Who is sponsoring the NCT06809829 clinical trial?
NCT06809829 is sponsored by Kafrelsheikh University. The trial plans to enroll 16 participants.